Somewhat Favorable News Coverage Somewhat Unlikely to Impact Agenus (AGEN) Share Price

Insider Trades for Agenus Inc. show that the latest trade was made on 2 Sep 2017 where Buell (Jennifer), the Officer completed a transaction type "Buy" in which 4375 shares were traded at a price of $3.72. AGEN's total short interest was 9.75 million shares in September as published by FINRA. About 40,613 shares traded. It has outperformed by 71.09% the S&P500. Also, the number of active investment managers holding Agenus Inc in their top 10 stock positions decreased from 2 to 0 for a decrease of 2. Agenus Inc (NASDAQ:AGEN) has declined 2.26% since September 14, 2016 and is downtrending. It has underperformed by 18.96% the S&P500.The move comes after 7 months positive chart setup for the $371.46 million company. We have $4.40 PT which if reached, will make NASDAQ:AGEN worth $11.14 million more.

Since April 10, 2017, it had 1 buy, and 0 sales for $334,520 activity. Relative Strength Index (RSI-14) for Agenus Inc.

Following previous thoughts, shifting focus on performance of the Agenus Inc.

3 analysts on average are expecting the company to report revenue of $5.31 Million for the current quarter. It now has negative earnings. It is developing a I-O portfolio driven by platforms and programs, such as antibody discovery platforms, including Retrocyte Display, SECANT yeast display and phage display technologies created to produce human antibodies; antibody candidate programs, including checkpoint modulator (CPM) programs; vaccine programs, including Prophage, AutoSynVax and PhosPhoSynVax, and saponin vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). Out of 5 Wall Street analysts rating Agenus, 4 give it "Buy", 0 "Sell" rating, while 1 recommend "Hold".

Ratings analysis reveals 50% of Agenus's analysts are positive. ValuEngine raised shares of Agenus from a "strong sell" rating to a "sell" rating in a research report on Monday, July 24th. The firm has "Market Outperform" rating given on Wednesday, March 9 by JMP Securities. Zurcher Kantonalbank Zurich Cantonalbank now owns 97,342 shares of the biotechnology company's stock valued at $367,000 after buying an additional 7,050 shares during the period. On Monday, July 27 the stock rating was maintained by MLV with "Buy".

Agenus (NASDAQ:AGEN) last issued its quarterly earnings data on Thursday, August 3rd.

Vanguard Group Inc. increased its stake in shares of Agenus Inc. The company was maintained on Thursday, October 27 by Maxim Group. H.C. Wainwright downgraded the shares of AGEN in report on Friday, October 28 to "Neutral" rating. The firm has "Buy" rating by Jefferies given on Monday, June 26.

Agenus Inc. (AGEN) is expected to post revenue of $5.31 Million in the current quarter, according to consensus of 3 analysts. Comparatively, Agenus Inc. posted earnings of $-0.29 per share in the same quarter past year. Its the same as in 2016Q3. American International Group Inc. lifted its stake in Agenus by 7.1% in the 1st quarter. Alphamark Limited Liability Corporation reported 0% in Agenus Inc (NASDAQ:AGEN). Assetmark Inc reported 19,360 shares.

The stock has Return on Assets (ROA) of -65.2 percent. Blackrock Institutional Tru Na stated it has 0% of its portfolio in Agenus Inc (NASDAQ:AGEN). Perceptive Advisors Limited Liability Corp invested in 0.02% or 72,187 shares. Art Advsrs Ltd Liability Com holds 0.01% or 24,700 shares in its portfolio. Qvt Lp has 0.51% invested in Agenus Inc (NASDAQ:AGEN). Manufacturers Life Ins The reported 52,841 shares. Commercial Bank Of New York Mellon holds 0% or 406,084 shares. Princeton Alpha L P invested 0.01% in Agenus Inc (NASDAQ:AGEN). Tiaa Cref Invest Mgmt Limited Liability Company invested 0% in Agenus Inc (NASDAQ:AGEN).

WARNING: "Agenus Inc. (NASDAQ:AGEN) Position Boosted by Credit Suisse AG" was first posted by StockNewsTimes and is owned by of StockNewsTimes.

Insider Trading is buying and selling of a security by a person who has access to material information related to a security that is not available to general public.

A stock rating usually tells investors how well a stock's market value relates to what analysts think is a fair value for the stock, based on an independent evaluation of the company. BioTelemetry had 5 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was maintained by Bank of America with "Buy" on Thursday, August 27.

The company reported its EPS on 6/29/2017.

Like this


15 September 2017
Major fire at LPG bottling plant in city
He said the alert official machinery had ensured that nobody was injured. People were seen running away from the vicinity of the godown.

15 September 2017
Kimberly-Clark Corporation (NYSE:KMB) Earns Hold Rating from Jefferies Group LLC
The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.03. Janus Henderson Group PLC increased its stake in shares of Kimberly-Clark Corporation by 5,178.3% in the second quarter.

15 September 2017
Boise State Football moves past OT loss to WSU
Prior to that, Boise State had won 110 consecutive games when leading by at least 21 points in the second half. The Boise State Broncos are ranked 85 on offense, averaging 381.0 yards per game.

15 September 2017
One in three drivers are distracted in school zones
New research from ZenDrive says between 4:00 and 5:00 in the afternoon is the most risky time to be on the roads near school. That's in contrast to Trinity Lutheran Church in Texas, which received an "F". "Police work is driven by information".

15 September 2017
Zach Braff Discovers He's Advertising Erection Pills In Russia
Other celebrities such as Ben Barnes and Zac Efron are also well versed in tech services, according to Twitter . This is not the first time devious ad men in the Eastern Bloc have appropriated Braff's face to hawk products.

15 September 2017
Jefferies Group LLC Reaffirms "Buy" Rating for Marathon Petroleum Corporation (NYSE:MPC)
Provides Update on Strategic Actions to Enhance ..." with publication date: "September 05, 2017 was also an interesting one. Massachusetts-based Pioneer Invest Mngmt Incorporated has invested 0.11% in Marathon Petroleum Corp (NYSE:MPC).

15 September 2017
Billionaire Barry Diller Abandons Dream Of Levitating Park On The Hudson
Richard Emery, a lawyer for the City Club, said in a statement they were "surprised" by the news. But it quickly stalled because of the ongoing litigation.

15 September 2017
Bullet Train Project in India: 10 things you should know
While Japan is providing the technology and funding for the project, India has to provide the human resources. Private high speed trains do good business in countries of the European Union, and also in the UK.

15 September 2017
Ashley Graham reckons Fenty x Puma lacked diversity
Her song "Wild Thoughts" was undeniably the tune of the summer and her latest Fashion Week showing was nothing short of spectacular.

15 September 2017
Internal Affairs Report Slams Officer Who Arrested Nurse
Salt Lake City Mayor Jackie Biskupski announced the investigation findings Wednesday in a news conference at City Hall. The University of Utah Hospital has barred police from its patient-care areas and from direct contact with its nurses.